Nick Damiano is the CEO of Andromeda Surgical (YC S23) and previously founded Zenflow, which achieved FDA Class 3 approval and treated over 300 patients. He co-founded Avail MedSystems, which was acquired by Mendaera after deploying across 1,000 hospitals. He holds a Stanford MS and BS, completed the Stanford Biodesign Innovation Fellowship, and has experience as a software engineer and venture partner.
Intro paths
Nick went through Y Combinator (Summer 2023) — any YC alum in your network can reach them through the YC community.
Their group partner at YC was Garry Tan, President & CEO of Y Combinator — the partner who ran Andromeda Surgical's batch and knows the company first-hand. YC profile ↗
In turn, Nick can intro founders to Andromeda Surgical's investors below.
Andromeda Surgical's investors · 9
Co-founders
